CA3 treatment (1 μM; 48 h) in PC cells reduced the protein expression levels of PAF1, YAP1, TEAD4, CD133 (cancer stem cell marker), and SOX9 (pancreatic ductal marker) (Fig. 4A–C). Here, TEAD4 is linked to cancer.